Back to search

An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype.

Data up to Jan 2025

Published2000
Citations78
References63

Total Citations Per Year

Abstract

References (63)

Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis

1996 • 6,878 citations

Induction of apoptosis in fibroblasts by c-myc protein

1992 • 2,977 citations

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

1983 • 2,871 citations

Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor

1983 • 2,350 citations

Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with Myc

1991 • 1,650 citations

Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1

1994 • 1,460 citations

The implications of angiogenesis for the biology and therapy of cancer metastasis

1994 • 1,120 citations

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

1990 • 1,062 citations

Molecular architecture of basement membranes

1990 • 937 citations

Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.

1997 • 841 citations

A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins

1995 • 798 citations

Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation

1984 • 785 citations

Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.

1995 • 766 citations

Role for c-myc in Activation-Induced Apoptotic Cell Death in T Cell Hybridomas

1992 • 705 citations

A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1

1987 • 696 citations

Cdc25 cell-cycle phosphatase as a target of c-myc

1996 • 691 citations

The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.

1999 • 638 citations

Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation

1995 • 603 citations

A murine tumor producing a matrix of basement membrane.

1977 • 602 citations

Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.

1999 • 599 citations

V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression.

1997 • 526 citations

How Tumors Become Angiogenic

1996 • 514 citations

Mice That Lack Thrombospondin 2 Display Connective Tissue Abnormalities That Are Associated with Disordered Collagen Fibrillogenesis, an Increased Vascular Density, and a Bleeding Diathesis

1998 • 488 citations

Myc and Max proteins possess distinct transcriptional activities

1992 • 478 citations

Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells

1989 • 475 citations

Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways

1997 • 470 citations

Reversible Activation of c-Myc in Skin

1999 • 468 citations

Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max

1992 • 458 citations

Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia.

1998 • 451 citations

The molecular role of Myc in growth and transformation: recent discoveries lead to new insights

1998 • 381 citations

Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ

1989 • 360 citations

c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II.

1994 • 313 citations

A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells

1990 • 313 citations

Myc target genes

1997 • 289 citations

Control of cell proliferation by Myc

1998 • 251 citations

IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: Demonstration of a novel role for c-myc

1992 • 242 citations

Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line.

1990 • 230 citations

Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines

1994 • 222 citations

Reciprocal paracrine interactions between tumour cells and endothelial cells: the ‘angiogenesis progression’ hypothesis

1996 • 212 citations

Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.

1996 • 210 citations

Inhibition of Angiogenesis by Thrombospondin-2

1995 • 200 citations

Angiogenesis in the Mouse Cornea

1979 • 188 citations

Temporally and spatially regulated somatic mutagenesis in mice

1998 • 187 citations

Role of the SIKVAV Site of Laminin in Promotion of Angiogenesis and Tumor Growth: An In Vivo Matrigel Model

1992 • 185 citations

Angiogenesis spectrum in the stroma of B‐cell non‐Hodgkin's lymphomas. An immunohistochemical and ultrastructural study

1996 • 183 citations

Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling

1991 • 175 citations

Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration.

1993 • 165 citations

Myc represses the growth arrest gene gadd45

1997 • 149 citations

Establishing a Link between Oncogenes and Tumor Angiogenesis

1998 • 148 citations

Neoplastic transformation by the human gene N-myc.

1987 • 124 citations

Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.

1996 • 121 citations

SPARC and thrombospondin genes are repressed by the c-jun oncogene in rat embryo fibroblasts.

1994 • 108 citations

Viral Myc Oncoproteins in Infected Fibroblasts Down-modulate Thrombospondin-1, a Possible Tumor Suppressor Gene

1996 • 92 citations

Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.

1990 • 82 citations

Cell cycle: On target with Myc

1996 • 81 citations

Assay and purification of naturally occurring inhibitor of angiogenesis

1991 • 73 citations

Down‐regulation of endothelial cell growth inhibitors by enhanced MYCN oncogene expression in human neuroblastoma cells

1999 • 60 citations

Establishment of a Cell Line from the EHS Tumor: Biosynthesis of Basement Membrane Constituents and Characterization of a Hybrid Proteoglycan Containing Heparan and Chondroitin Sulfate Chains

1992 • 50 citations

Transformation by v-src causes transient induction followed by repression of mouse thrombospondin-1.

1994 • 50 citations

Tumour suppressor genes and angiogenesis: the role of TP53 in fibroblasts

1996 • 38 citations

Myb-dependent Regulation of Thrombospondin 2 Expression

1998 • 34 citations

Overproduction of v-Myc in the Nucleus and Its Excess Over Max Are Not Required for Avian Fibroblast Transformation

1993 • 13 citations

Characterization of c-myc-Transformed Rat Fibroblasts Resistant to Apoptosis Induced by Growth Factor Deprivation

1996 • 6 citations

Cited By (0)

No citing papers found in database

An in vivo function for the transforming Myc protein: elicitation of the angiogenic… (2000) – PubMed | Metascience Observatory Explorer